查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1765431

全球經導管栓塞及阻塞設備市場

Transcatheter Embolization and Occlusion Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球經導管栓塞和阻塞設備市場規模將達到 68 億美元

全球經導管栓塞和阻塞設備市場規模預計在2024年為46億美元，預計到2030年將達到68億美元，2024年至2030年的複合年成長率為6.6%。栓塞線圈是本報告分析的細分市場之一，預計其複合年成長率為7.1%，到分析期結束時規模將達到28億美元。此外，栓塞輔助裝置細分市場在分析期間的複合年成長率預計為5.9%。

美國市場規模估計為 13 億美元，中國市場預期複合年成長率為 6.1%

美國經導管栓塞和阻塞設備市場規模預計在2024年達到13億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到10億美元，在2024-2030年的分析期間內，複合年成長率為6.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.2%和5.2%。在歐洲，預計德國市場的複合年成長率為5.4%。

全球經導管栓塞和阻塞設備市場—主要趨勢和促進因素摘要

什麼是經導管栓塞和阻塞設備？為什麼它們在醫療保健中很重要？

經導管栓塞和阻塞設備是用於阻塞和閉塞血管的醫療器械，主要用於介入放射學和微創手術等各種治療應用。它們用於治療動脈瘤、動靜脈畸形 (AVM)、腫瘤、異常出血等。這些器械的主要目的是阻斷流向目標區域的血流，從而促進治療並降低手術過程中併發症的風險。這些器械在血管疾病管理中發揮關鍵作用，是現代醫療保健中必不可少的工具，為患者提供了一種與傳統手術相比侵入性較小的治療方法。

血管疾病的日益普及、介入技術的進步以及對微創手術日益成長的需求，推動了經導管栓塞和阻塞設備在全球範圍內的普及。隨著全球人口老化以及動脈瘤、癌症和周邊血管疾病等疾病發生率的上升，對有效栓塞和封鎖手術的需求日益成長。此外，影像技術和導管介入手術的進步提高了這些手術的安全性和有效性，鼓勵醫療保健提供者採用經導管手術。人們越來越重視透過微創干預來改善患者預後，這推動了全球經導管栓塞和阻塞設備市場的擴張。

技術進步如何影響經導管栓塞和阻塞設備的發展？

技術進步顯著改善了經導管栓塞和阻塞設備的設計和功能，從而改善了治療效果並提高了醫療程序的效率。一項顯著的創新是用於栓塞裝置的生物可吸收和生物分解性材料的開發。這些先進的材料可以暫時閉塞血管，從而降低永久性植入相關的長期併發症風險。使用生物可吸收裝置可以在癒合後恢復正常血流，這在治療血管病變和其他病症方面具有重大優勢。

推動市場發展的另一個關鍵技術進步是經導管治療與先進影像技術的結合。錐狀射束電腦斷層掃描 (CBCT) 和術中超音波等技術正被用於提高栓塞手術的可視化程度和精準度。這些改進的影像能力使我們能夠更好地評估血管解剖結構，更精確地放置栓塞裝置，最終提高手術成功率。先進影像技術與經導管技術的結合正在徹底改變栓塞和閉塞手術的方法，使栓塞治療對患者更安全、更有效。

此外，混合型和多功能設備的開發正在擴展經導管栓塞系統的功能。製造商越來越注重開發具有多種功能的設備，例如在輸送栓塞劑的同時進行其他治療性介入。這種功能整合簡化了流程，減少了對多台設備的需求，最終提高了效率並改善了患者照護。對多功能性和創新性的重視正在塑造經導管栓塞和阻塞設備的未來，為醫療保健專業人員提供更多功能齊全的工具來應對複雜的血管疾病。

是什麼推動了各種醫療保健環境中採用經導管栓塞和阻塞設備？

經導管栓塞和阻塞設備的普及受多種關鍵因素驅動，包括血管疾病盛行率的不斷上升、對微創手術的需求不斷成長，以及對患者安全和治療效果的日益關注。其中一個主要促進因素是動脈瘤和周邊動脈疾病等血管疾病的盛行率不斷上升，這些疾病需要有效的治療方案。人口老化和慢性病發病率的不斷上升，推動了對能夠安全有效地管理這些疾病的經導管解決方案的需求。醫療保健提供者越來越依賴栓塞和阻塞設備來治療患者，從而推動了市場應用。

影響經導管栓塞和阻塞設備應用的另一個關鍵因素是微創手術需求的持續成長。患者和醫護人員越來越青睞那些能夠減少手術創傷、加快恢復時間並最大程度減少併發症的技術。經導管手術具有顯著優勢，包括縮短住院時間和加快恢復速度，使其成為對病患和醫護人員都極具吸引力的選擇。這種向微創方法的轉變推動了栓塞和阻塞設備的普及，這些裝置為治療血管疾病提供了一種無需開放性手術的有效解決方案。

此外，對病人安全和臨床療效改善的日益關注，推動了經導管栓塞和阻塞設備在各種醫療環境中的應用。隨著醫療保健提供者優先使用能夠增強安全性並最大程度降低風險的裝置，對先進栓塞和封堵解決方案的需求也日益成長。更安全、更有效的裝置的開發，以及改進的使用訓練和通訊協定，正在促進患者療效的改善和滿意度的提升。對安全性和優質照護的關注，正在推動醫療機構更廣泛地採用經導管栓塞和阻塞設備。

推動全球經導管栓塞和阻塞設備市場成長的因素是什麼？

全球經導管栓塞和阻塞設備市場的成長受到多種因素的推動，包括醫療基礎設施投資的增加、醫療技術的不斷進步以及個人化醫療趨勢的興起。其中一個主要成長要素是醫療基礎設施投資的增加，旨在改善患者照護並擴大先進醫療手段的可近性。各國政府和醫療機構正在投入資源升級醫療設施，尤其是在新興經濟體，導致介入放射學和栓塞治療的應用日益普及。對有效治療血管疾病的需求正在推動醫療基礎設施投資的增加，從而支持經導管栓塞和阻塞設備市場的成長。

市場成長的另一個主要驅動力是醫療技術的不斷進步，這些技術提高了經導管手術的有效性和安全性。創新栓塞材料、改進的影像技術和先進的輸送系統的開發，使醫療保健提供者能夠更精確、更可靠地執行手術。隨著製造商持續投入研發，開發能夠改善性能和患者預後的新產品，預計對經導管栓塞和阻塞設備的需求將會增加。這種對創新的關注有助於企業在競爭中脫穎而出，從而推動市場成長。

此外，個人化醫療的日益成長趨勢也推動了經導管栓塞和阻塞設備市場的成長。隨著醫療保健逐漸轉向更個人化的治療方法，對有針對性且有效的栓塞解決方案的需求日益成長。經導管裝置可以根據患者獨特的解剖和臨床特徵進行客製化，以滿足其特定需求。隨著醫療保健專業人員尋求提高治療效果並改善患者預後，這種對個人化治療的關注正在推動經導管解決方案的普及。

此外，醫療專業人員和患者對微創技術及其益處的認知不斷提高，也影響經導管栓塞和阻塞設備市場的成長。隨著越來越多的從業者認知到使用經導管技術治療血管疾病的益處，預計這些裝置的採用率將會增加。對改善手術技術和病人安全的重視，正推動醫療機構投資先進的經導管栓塞和阻塞設備。隨著這些因素繼續塑造市場格局，醫療基礎設施投資的增加、醫療技術的不斷進步以及個人化醫療的日益成長，將推動市場格局的強勁成長。

部分

產品類型（栓塞線圈、栓塞輔助裝置、栓塞顆粒、液體導流裝置、液體栓塞、配件）

受訪公司範例

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個來自全球專家的精選內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16866

Global Transcatheter Embolization and Occlusion Devices Market to Reach US$6.8 Billion by 2030

The global market for Transcatheter Embolization and Occlusion Devices estimated at US$4.6 Billion in the year 2024, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Embolization Coils, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Coiling Assist Devices segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.1% CAGR

The Transcatheter Embolization and Occlusion Devices market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Transcatheter Embolization and Occlusion Devices Market - Key Trends & Drivers Summarized

What Are Transcatheter Embolization and Occlusion Devices and Why Are They Critical in Medical Procedures?

Transcatheter embolization and occlusion devices are medical instruments used to block or occlude blood vessels in various therapeutic applications, primarily in interventional radiology and minimally invasive surgery. These devices include a range of products such as embolic agents (coils, particles, and gels) and occlusion balloons, which are employed to treat conditions like aneurysms, arteriovenous malformations (AVMs), tumors, and abnormal bleeding. The primary purpose of these devices is to prevent blood flow to targeted areas, thereby facilitating treatment and reducing the risk of complications during surgical procedures. Their critical role in managing vascular conditions makes them essential tools in modern healthcare, offering patients less invasive treatment options compared to traditional surgery.

The global adoption of transcatheter embolization and occlusion devices is driven by the increasing prevalence of vascular diseases, advancements in interventional techniques, and the growing demand for minimally invasive procedures. As the global population ages and the incidence of conditions such as aneurysms, cancer, and peripheral vascular disease rises, the need for effective embolization and occlusion solutions has become more pronounced. Additionally, ongoing advancements in imaging technologies and catheter-based techniques have enhanced the safety and efficacy of these procedures, encouraging healthcare providers to adopt transcatheter methods. The emphasis on improving patient outcomes through less invasive interventions is propelling the expansion of the global transcatheter embolization and occlusion devices market.

How Are Technological Advancements Shaping the Development of Transcatheter Embolization and Occlusion Devices?

Technological advancements are significantly enhancing the design and functionality of transcatheter embolization and occlusion devices, leading to improved outcomes and greater efficiency in medical procedures. One notable innovation is the development of bioresorbable and biodegradable materials for embolic devices. These advanced materials allow for temporary occlusion of blood vessels, reducing the risk of long-term complications associated with permanent implants. The use of bioresorbable devices enables the restoration of normal blood flow once healing has occurred, providing a significant advantage in managing vascular lesions and other conditions.

Another key technological advancement driving the market is the integration of advanced imaging techniques with transcatheter procedures. Technologies such as cone beam computed tomography (CBCT) and intraoperative ultrasound are being utilized to enhance visualization and precision during embolization procedures. This improved imaging capability allows for better assessment of vascular anatomy and more accurate placement of embolic devices, ultimately leading to increased procedural success rates. The combination of advanced imaging and transcatheter techniques is revolutionizing the approach to embolization and occlusion, making these devices safer and more effective for patients.

Furthermore, the development of hybrid and multifunctional devices is expanding the capabilities of transcatheter embolization systems. Manufacturers are increasingly focusing on creating devices that can perform multiple functions, such as delivering embolic agents while simultaneously providing access for other therapeutic interventions. This integration of functions can streamline procedures and reduce the need for multiple devices, ultimately enhancing efficiency and improving patient care. The emphasis on multifunctionality and innovation is shaping the future of transcatheter embolization and occlusion devices, providing healthcare professionals with more versatile tools to address complex vascular conditions.

What Factors Are Driving the Adoption of Transcatheter Embolization and Occlusion Devices Across Various Healthcare Settings?

The adoption of transcatheter embolization and occlusion devices is being driven by several key factors, including the increasing prevalence of vascular diseases, the rising demand for minimally invasive procedures, and the growing focus on patient safety and outcomes. One of the primary drivers is the increasing prevalence of vascular diseases, such as aneurysms and peripheral artery disease, which require effective treatment options. As the aging population and the incidence of chronic diseases continue to rise, the demand for transcatheter solutions that can safely and effectively manage these conditions is escalating. Healthcare providers are increasingly relying on embolization and occlusion devices to treat patients, thereby driving market adoption.

Another significant factor influencing the adoption of transcatheter embolization and occlusion devices is the rising demand for minimally invasive procedures. Patients and healthcare professionals are increasingly favoring techniques that reduce surgical trauma, shorten recovery times, and minimize complications. Transcatheter procedures offer significant benefits, including reduced hospital stays and faster recuperation, making them appealing options for both patients and providers. This shift towards minimally invasive approaches is driving the adoption of embolization and occlusion devices, as they provide effective solutions for treating vascular issues without the need for open surgery.

Moreover, the growing focus on patient safety and improved clinical outcomes is driving the adoption of transcatheter embolization and occlusion devices across various healthcare settings. As healthcare providers prioritize the use of devices that enhance safety and minimize risks, the demand for advanced embolization and occlusion solutions is increasing. The development of safer and more effective devices, along with improved training and protocols for their use, is contributing to better patient outcomes and higher satisfaction rates. This emphasis on safety and quality care is encouraging healthcare facilities to adopt transcatheter embolization and occlusion devices more widely.

What Is Driving the Growth of the Global Transcatheter Embolization and Occlusion Devices Market?

The growth in the global Transcatheter Embolization and Occlusion Devices market is driven by several factors, including rising investments in healthcare infrastructure, increasing advancements in medical technologies, and the growing trend towards personalized medicine. One of the primary growth drivers is the rising investment in healthcare infrastructure aimed at improving patient care and expanding access to advanced medical treatments. Governments and healthcare organizations are increasingly allocating resources to upgrade medical facilities, particularly in emerging economies, leading to an increased adoption of interventional radiology and embolization techniques. The demand for effective treatment of vascular conditions is driving investments in healthcare infrastructure, thereby supporting the growth of the transcatheter embolization and occlusion devices market.

Another significant driver of market growth is the increasing advancements in medical technologies that enhance the efficacy and safety of transcatheter procedures. The development of innovative embolization materials, improved imaging technologies, and advanced delivery systems is enabling healthcare providers to perform procedures with greater precision and confidence. As manufacturers continue to invest in R&D and develop new products that offer improved performance and patient outcomes, the demand for transcatheter embolization and occlusion devices is expected to rise. This focus on innovation is fostering market growth as companies seek to differentiate their offerings in a competitive landscape.

Moreover, the growing trend towards personalized medicine is supporting the growth of the transcatheter embolization and occlusion devices market. As healthcare moves towards more individualized treatment approaches, the need for targeted and effective embolization solutions is becoming increasingly important. Transcatheter devices can be tailored to meet the specific needs of patients, taking into account their unique anatomical and clinical characteristics. This focus on personalized care is driving the adoption of transcatheter solutions, as healthcare providers seek to enhance treatment efficacy and improve patient outcomes.

Furthermore, the increasing awareness of minimally invasive techniques and their benefits among healthcare providers and patients is influencing the growth of the transcatheter embolization and occlusion devices market. As more practitioners recognize the advantages of using transcatheter methods to treat vascular conditions, the adoption of these devices is expected to increase. The emphasis on improving surgical techniques and patient safety is driving healthcare facilities to invest in advanced transcatheter embolization and occlusion devices. As these factors continue to shape the market landscape, the transcatheter embolization and occlusion devices market is poised for robust growth, driven by rising investments in healthcare infrastructure, increasing advancements in medical technologies, and a growing trend towards personalized medicine.

SCOPE OF STUDY:

The report analyzes the Transcatheter Embolization and Occlusion Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics, Accessories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Transcatheter Embolization and Occlusion Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Vascular Disorders and Aneurysms Drives Demand for Transcatheter Embolization and Occlusion Devices
    • Increased Adoption of Minimally Invasive Surgeries Expands Addressable Market for Transcatheter Embolization Devices
    • Surge in Demand for Transcatheter Embolization Devices in Cancer and Tumor Treatments Fuels Market Growth
    • Increased Use of Transcatheter Embolization Devices in Trauma and Emergency Care Settings Fuels Market Expansion
    • Technological Innovations in Bioabsorbable and Biocompatible Embolic Devices Propel Market Growth
    • Growing Use of Transcatheter Embolization Devices in Stroke Management and Neurovascular Interventions Strengthens Business Case
    • Surge in Adoption of Transcatheter Occlusion Devices in Congenital Heart Defect Treatments Fuels Market Demand
    • Rising Adoption of Transcatheter Devices in Liver and Kidney Tumor Embolization Expands Market Opportunities
    • Rising Use of Transcatheter Embolization Devices in Postpartum Hemorrhage and Uterine Fibroid Embolization Strengthens Business Case
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transcatheter Embolization and Occlusion Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolization Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coiling Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Flow Diverting Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Liquid Embolics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030

IV. COMPETITION